Video Experimental Relacionado
Updated: Aug 11, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Algunas reflexiones sobre los ensayos clínicos, especialmente los problemas de multiplicidad
Science (New York, N.Y.)
|November 18, 1977
Resumen
Las consideraciones éticas y el consentimiento informado en los ensayos clínicos complican el diseño experimental, lo que potencialmente impide respuestas definitivas a las preguntas de investigación. Esto puede conducir a enfoques y diseños estadísticos alternativos.
Área de la Ciencia:
- Metodología de la investigación clínica.
- Bioética y bioética.
- Diseño experimental de diseño.
Sus antecedentes:
- Los ensayos clínicos se enfrentan a desafíos significativos en el diseño estadístico y conceptual.
- Las consideraciones éticas, particularmente el consentimiento informado, impactan cada vez más en la conducta de los ensayos.
Objetivo del estudio:
- Explorar la compleja interacción entre las cuestiones éticas y el diseño experimental en ensayos clínicos.
- Discutir las implicaciones de las restricciones éticas en la capacidad de responder a las preguntas de investigación de manera definitiva.
Principales métodos:
- Análisis conceptual de los principios éticos en el diseño de ensayos clínicos.
- Revisión de las posibles consecuencias para las metodologías estadísticas y los enfoques experimentales.
Principales resultados:
- Los requisitos éticos, como el consentimiento informado, plantean obstáculos significativos para obtener pruebas claras y cuantitativas de la efectividad.
- Estas restricciones éticas pueden requerir el uso de diseños experimentales alternativos o modificados.
Conclusiones:
- Los imperativos éticos en los ensayos clínicos crean dificultades inherentes en el diseño experimental y la interpretación de los datos.
- Estrategias como límites desequilibrados, diseños de enfoque hacia abajo y controles históricos pueden surgir como consecuencias de estas demandas éticas y regulatorias.
Más Videos Relacionados
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Videos de Conceptos Relacionados
01:22Case Studies
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...